Quarterly report [Sections 13 or 15(d)]

Cash, Cash Equivalents, and Marketable Securities

v3.26.3
Cash, Cash Equivalents, and Marketable Securities
9 Months Ended
Sep. 30, 2026
Cash, Cash Equivalents, and Marketable Securities [Abstract]  
Cash, Cash Equivalents, and Marketable Securities

3. Cash, Cash Equivalents, and Marketable Securities

 

The following table summarizes the Company’s investments as of September 30, 2026 (in thousands):

 

   

Amortized

Cost Basis

   

Unrealized

Gains

   

Unrealized

Losses

   

Estimated

Fair Value

 
                         
Cash   $ 41,966     $     -     $ -     $ 41,966  
Investments in corporate bonds     17,032       -       (26 )     17,006  
Total cash, cash equivalents and investments in marketable securities   $ 58,998     $ -     $ (26 )   $ 58,972  

 

The following table summarizes the Company’s investments as of December 31, 2025 (in thousands):

 

   

Amortized

Cost Basis

   

Unrealized

Gains

   

Unrealized

Losses

   

Estimated

Fair Value

 
                         
Cash   $ 24,172     $     -     $ -     $ 24,172  
U.S. Treasury Bills     3,449       -       -       3,449  
Money Market     1,577                       1,577  
Investments in corporate bonds     12,072       -       (1 )     12,071  
Total cash, cash equivalents and investments in marketable securities   $ 41,270     $ -     $ (1 )   $ 41,269  

 

The Company classifies its investments in corporate bonds as available-for-sale. Unrealized gains and losses on these securities are included as a component of comprehensive loss. The Company’s investments in corporate bonds as of September 30, 2026, are $17.0 million and as of December 31, 2025, were $12.1 million.

 

On September 30, 2026, the remaining contractual maturities of all the Company’s available-for-sale investments were less than twelve months. As of September 30, 2026, the Company has not established an allowance for credit losses for any of its available-for-sale securities.